Immunohistochemical analysis of beta-catenin, E-cadherin and p53 in canine gastrointestinal epithelial tumors.
beta-catenin
carcinogenesis
dog
gastrointestinal neoplasm
immunohistochemistry
Journal
The Journal of veterinary medical science
ISSN: 1347-7439
Titre abrégé: J Vet Med Sci
Pays: Japan
ID NLM: 9105360
Informations de publication
Date de publication:
24 Sep 2020
24 Sep 2020
Historique:
pubmed:
14
7
2020
medline:
29
7
2021
entrez:
14
7
2020
Statut:
ppublish
Résumé
Wnt/beta-catenin signaling, E-cadherin and p53 reportedly play important roles in the development and/or progression of human gastrointestinal cancer. The present study evaluated the roles of beta-catenin, E-cadherin and p53 in canine gastrointestinal tumors. Endoscopic biopsy or surgically resected samples, a total of 131, including 38 gastric, 13 small intestinal and 80 large intestinal tumors, were obtained from 95 dogs. Those specimens were examined pathologically. Immunohistochemically, nuclear beta-catenin expression was found in 88% (42/48) of polypoid type adenocarcinomas. Most cases of non-polypoid type adenocarcinomas lacked nuclear expression of beta-catenin with the exception of one case (6%, 1/17). Nuclear beta-catenin expression was not observed in signet ring cell carcinomas (0/15), mucinous adenocarcinomas (0/7) and undifferentiated carcinomas (0/4). The findings indicate that nuclear translocation of beta-catenin is closely related to the development of polypoid type adenocarcinomas but not that of non-polypoid type malignant tumors. The immunoreactivity of E-cadherin for tumor cells tended to decline overall in most of cases including benign tumors. Significant immunoreactivity for p53 was not found in 61% of tumors examined (80/131), including malignant tumors (63%, 57/91), while intense p53-immunoreactivity was rarely found in a few cases of malignant tumors (8%, 7/91). We could not conclude clearly significant correlations between histopathological tumor types and immunohistochemical results of E-cadherin or p53. This paper indicates the importance of the nuclear translocation of beta-catenin for the tumorigenesis of canine intestinal polypoid type adenocarcinomas, especially in the colorectum.
Identifiants
pubmed: 32655099
doi: 10.1292/jvms.20-0297
pmc: PMC7538321
doi:
Substances chimiques
Cadherins
0
Tumor Suppressor Protein p53
0
beta Catenin
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1277-1286Références
Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):3046-50
pubmed: 7708772
Cancer Cell Int. 2003 Oct 14;3(1):17
pubmed: 14613514
Am J Pathol. 1991 Jul;139(1):17-23
pubmed: 1713020
Cancer. 1988 Feb 15;61(4):829-34
pubmed: 3338040
Surg Today. 1998;28(6):587-94
pubmed: 9681606
Carcinogenesis. 2020 May 23;:
pubmed: 32445578
Cancer Res. 1994 Jun 1;54(11):2841-4
pubmed: 8187064
Proc Natl Acad Sci U S A. 1990 Oct;87(19):7555-9
pubmed: 1699228
Cancer Res. 1994 Jan 1;54(1):291-6
pubmed: 8261454
Hum Mutat. 2003 Mar;21(3):258-70
pubmed: 12619111
Cancer Med. 2015 Jan;4(1):75-83
pubmed: 25354498
Mol Cell Biol. 1984 Mar;4(3):442-8
pubmed: 6325878
Cell. 1996 Oct 18;87(2):159-70
pubmed: 8861899
Am J Pathol. 1993 Jan;142(1):87-93
pubmed: 7678722
Cancer Res. 1994 Sep 1;54(17):4798-804
pubmed: 8062281
J Toxicol Pathol. 2017 Jul;30(3):239-243
pubmed: 28798532
Mol Cell Biol. 1988 Feb;8(2):531-9
pubmed: 2832726
Br J Cancer. 1993 Sep;68(3):507-14
pubmed: 8353041
Mod Pathol. 2017 Mar;30(3):382-392
pubmed: 27934876
J Biomed Biotechnol. 2011;2011:567305
pubmed: 22007144
Cancer Res. 1993 Apr 1;53(7):1690-5
pubmed: 8453643
Methods Mol Biol. 2016;1422:309-27
pubmed: 27246043
Oncol Rep. 2001 Nov-Dec;8(6):1215-9
pubmed: 11605035
Anticancer Res. 2009 Aug;29(8):2919-25
pubmed: 19661296
Princess Takamatsu Symp. 1991;22:285-92
pubmed: 1668888
PLoS One. 2012;7(12):e50813
pubmed: 23251390
Cell. 1991 Jul 12;66(1):107-19
pubmed: 2070412
J Cell Biol. 1991 Apr;113(1):173-85
pubmed: 2007622
Cell. 1991 Aug 9;66(3):589-600
pubmed: 1651174
Res Vet Sci. 2010 Dec;89(3):409-14
pubmed: 20457460
Cancer. 1983 May 1;51(9):1760-3
pubmed: 6831372
Jpn J Cancer Res. 1997 Aug;88(8):718-24
pubmed: 9330602
Science. 1997 Mar 21;275(5307):1787-90
pubmed: 9065402
Cold Spring Harb Perspect Biol. 2009 Dec;1(6):a003129
pubmed: 20457567
Am J Vet Res. 1997 Aug;58(8):857-63
pubmed: 9256970
Cancer Res. 1992 Jul 15;52(14):3965-71
pubmed: 1319835
J Biol Chem. 2000 Nov 3;275(44):34399-406
pubmed: 10906131
Jpn J Cancer Res. 1994 Mar;85(3):266-73
pubmed: 8188525
Gastroenterology. 1994 Jun;106(6):1436-43
pubmed: 8194688
Cancer Res. 1991 Apr 15;51(8):2185-92
pubmed: 2009537
Jpn J Cancer Res. 1996 Aug;87(8):843-8
pubmed: 8797891
Br J Cancer. 2000 Jan;82(1):9-15
pubmed: 10638959
Cancer Res. 2007 May 1;67(9):4079-87
pubmed: 17483318
Acta Pathol Jpn. 1987 Jan;37(1):21-37
pubmed: 3033988
Cancer. 1989 Sep 1;64(5):1138-46
pubmed: 2758387
JAMA. 2008 Mar 5;299(9):1027-35
pubmed: 18319413
N Engl J Med. 1988 Sep 1;319(9):525-32
pubmed: 2841597
Chin J Cancer. 2016 Jan 06;35:4
pubmed: 26738600
Int J Cancer. 1995 Feb 20;64(1):47-51
pubmed: 7665248
Vet Pathol. 2011 Jan;48(1):322-9
pubmed: 20587688
World J Exp Med. 2015 May 20;5(2):84-102
pubmed: 25992323
J Korean Med Sci. 2002 Feb;17(1):23-8
pubmed: 11850584
Virchows Arch. 2002 May;440(5):453-60
pubmed: 12021919
Vet Pathol. 1999 May;36(3):228-36
pubmed: 10332831
Hum Mol Genet. 1992 Sep;1(6):387-90
pubmed: 1338760
Cancer. 2003 Jan 15;97(2):389-404
pubmed: 12518363
Radiology. 1996 Oct;201(1):226-32
pubmed: 8816548
J Toxicol Pathol. 2020 Apr;33(2):105-113
pubmed: 32425343
Science. 1991 Aug 9;253(5020):661-5
pubmed: 1651562
Vet Comp Oncol. 2017 Sep;15(3):692-705
pubmed: 27549077
Vet Pathol. 1997 Sep;34(5):394-404
pubmed: 9381650
PLoS One. 2012;7(9):e46665
pubmed: 23029563